U.S. Pharmacist Weekly News Update
May 23, 2019

Common BPH Drugs Can Delay Prostate Cancer Diagnoses
Pharmacists should be aware that the prescriptions they fill for common benign prostatic hyperplasia (BPH) drugs might be delaying prostate cancer diagnoses in those patients. A new study also warns that when the cancer is diagnosed, it more frequently is more advanced in patients using drugs that inhibit the enzyme 5-alpha-reductase. Find out more.


Progesterone Increases Live Births in a Subset of Women With Early Bleeding
Although a recent clinical trial wasn’t as conclusive as researchers had hoped, it did provide evidence that progesterone can help some expectant mothers who have bleeding in early pregnancy who previously had multiple miscarriages. Find out how many more live births occurred with use of the common hormone versus a placebo.

Some Biologics Might Be
Safer Than Older Treatment
in Psoriasis

As pharmacists know, the greatest concern in treating psoriasis patients with biologic medications is the risk of infection. A new study might provide some reassurance, however, finding that some of the biologics might actually be safer than older medications. Here are more details.

Clinical Features, Not Five Clusters, Better for Determining T2D Therapy
Simpler might be better when it comes to determining the best treatment for type 2 diabetes (T2D), according to a new study. Find out why straightforward information such as sex, age at diagnosis, and baseline renal function can be used to better personalize the approach.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App